We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Whole Blood Controls Monitor Immunosuppressant Drug Test Precision

By LabMedica International staff writers
Posted on 29 Oct 2012

Image: Five levels of Lyphocheck Whole Blood Immunosuppressant Control (Photo courtesy of Bio-Rad).

Image: Five levels of Lyphocheck Whole Blood Immunosuppressant Control (Photo courtesy of Bio-Rad).

A lyophilized, third party, human whole blood based control offers five individual levels and includes Cyclosporine, Tacrolimus, and Sirolimus.

The control can be used with immunoassay or chromatographic techniques. Called the Lyphochek Whole Blood Immunosuppressant Control, it was designed for use as an assayed quality control material to monitor the precision of immunosuppressant drug test procedures in the clinical laboratory from low to very high concentrations. Immunosuppressant drugs are typically used in transplant therapy to help minimize organ rejection. Lyphochek Control is supplied as a whole blood based material that can be processed in the same manner as patient samples.

Bio-Rad Laboratories, Inc. (Hercules, CA, USA), a manufacturer and distributor of life science clinical diagnostics and research products, released the Lyphochek Whole Blood Immunosuppressant Control.

The company offers technical support and troubleshooting assistance for the control. The Unity Interlaboratory Program and the Unity Real Time, a data management-software solution designed to improve the effectiveness of quality control processes, are available for use with the Lyphochek Control.

Related Links:
Bio-Rad Laboratories - TDM controls
Bio-Rad Laboratories, Inc.

Visit expo >

Gold Member

Antipsychotic TDM Assays

Saladax Antipsychotic Assays

3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler

New

Myocardial Infarction Test

Finecare cTn I/NT-proBNP Rapid Quantitative Test

New

See-Saw Rocking Shaker

SH-200D-S-L

Latest Hematology News

Channels

Clinical Chemistry

view channel

Image: The new research involved using digital PCR as a reference method to standardize test results between laboratories (Photo courtesy of Adobe Stock)

New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results

Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more

Image: A pen-like tool collects molecules from the skin that can be screened for opioids (Photo courtesy of William Clarke/Johns Hopkins)

Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin

Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read more

Image: The spectroscopy and AI-powered urine-based test detects 10 cancers (Photo courtesy of 123RF)

Simple Urine Test Could Detect Multiple Cancers at Early Stage

When disease is present, the human body releases tiny molecules known as volatile organic compounds (VOCs). Now, a spectroscopy and artificial intelligence (AI)-powered urine-based test uses scent-based... Read more

Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel

Image: Multitasking ctDNA can help guide lymphoma treatment (Photo courtesy of 123RF)

PET/ctDNA-Guided Approach Helps Determine Lymphoma Treatment

Currently, no diagnostic tests exist that can determine the genetic profile of a tumor in diffuse large B-cell lymphoma (DLBCL) before treatment, a critical factor for choosing the appropriate therapy.... Read more

Image: A rapid POC mNGS solution could achieve rapid turnaround diagnostics for respiratory viruses (Photo courtesy of 123RF)

Next-Generation 'Agnostic Diagnostics' to Detect Respiratory Viruses at POC

An international consortium is working on the development of rapid metagenomic next-generation sequencing (mNGS) tools that can detect both known and emerging respiratory pathogens, with the goal of shortening... Read more

Image: Kissing bugs can carry the parasite that causes Chagas disease (Photo courtesy of 123RF)

First-Ever Test of Cure for Chagas Disease Determines Treatment Effectiveness

An estimated 6 to 8 million individuals across the globe are infected with Trypanosoma cruzi, the parasite responsible for Chagas disease, which claims over 10,000 lives annually. This disease doesn’t... Read more

Image: Capsule sponge opened to reveal the sponge (Photo courtesy of StillVision)

Capsule Sponge Test Could Replace Endoscopies for Monitoring Esophageal Cancer Risk

Esophageal cancer remains a challenging disease to treat, with fewer than 20% of patients surviving beyond five years of diagnosis—a statistic that has remained largely unchanged for decades.... Read more

Immunology

view channel

Image: Schematic overview of the deep learning-based circulating exosome analysis for lung cancer detection (Photo courtesy of Chuan Xu, Cheng Jiang)

Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer

Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more

Image: The new tool shines a light on elusive genomic patterns (Photo courtesy of Adobe Stock)

Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance

Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read more

Image: NGS can detect one tumor cell among a million healthy cells from a simple blood sample (Photo courtesy of Shutterstock)

New Tool Detects Breast Cancer Relapses Five Years in Advance

Relapse detection in patients with solid tumors—particularly hormone receptor-positive (HR+) breast cancer—remains a major clinical challenge, as many patients initially respond well to treatment but later... Read more

T Cells in Blood Can Detect Parkinson's Years Before Diagnosis

Diagnosing Parkinson’s disease before the appearance of motor symptoms remains one of neurology’s most significant challenges. Patients can go years—even decades—without a diagnosis, as subtle early indicators... Read more

Microbiology

view channel

Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients

Critically ill patients in medical intensive care units (MICUs) often suffer from conditions such as acute respiratory distress syndrome (ARDS) or sepsis, which are linked to reduced diversity of gut microbiota... Read more

Image: Lodestar UTI tests for six pathogen that, together, cause about 85% of all UTI infections (Photo courtesy of Llusern Scientific)

Portable Molecular POC System Rules Out UTIs in Just 35 Minutes

Urinary tract infections (UTIs) represent a massive burden on patients and healthcare systems. There are over 400 million UTI cases globally each year, of which around 90% are in women. Fast and accurate... Read more

POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques

Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read more

Image: The U.S. FDA-cleared IntelliSep rapid host response diagnostic represents a breakthrough in sepsis care (Photo courtesy of Cytovale)

Rapid Diagnostic Test Slashes Sepsis Mortality by 39%

Sepsis remains one of the most challenging and fatal conditions in contemporary healthcare, accounting for nearly one-third of all hospital-related deaths in the United States. In emergency departments... Read more

Pathology

view channel

Image: Example of multiple amplification of several targets as occurs in the syndromic panel (Photo courtesy of Marco Ciotti, Eleonora Nicolai, Massimo Pieri)

Advances in Monkeypox Virus Diagnostics to Improve Management of Future Outbreaks

Laboratory medicine plays a critical role in the diagnostic process, providing support for clinical decisions and guiding therapeutic interventions. The COVID-19 pandemic clearly demonstrated the vital... Read more

Nanoneedle-Studded Patch Could Eliminate Painful and Invasive Biopsies

Biopsies are among the most frequently performed diagnostic procedures globally, carried out millions of times each year to detect various diseases. Despite their importance, they are invasive, can lead... Read more

Image: The AI tool is set to transform the characterization and treatment of cancers (Photo courtesy of Garvan Institute)

AI Cancer Classification Tool to Drive Targeted Treatments

Tumors consist of more than just one type of cell—they are composed of a variety of cells that grow and respond to treatment in different ways. This variation, known as heterogeneity, poses a significant... Read more

Image: AI can help researchers understand lung disease and proposes treatment (Photo courtesy of YSM)

AI-Powered Imaging Enables Faster Lung Disease Treatment

Idiopathic pulmonary fibrosis (IPF) is a chronic and incurable lung disease that causes progressive scarring of lung tissue, severely impairing a person’s ability to breathe. Current treatments can only... Read more

Technology

view channel

New POC Biosensing Technology Improves Detection of Molecular Biomarkers

Traditional diagnostic procedures in medicine typically involve sending a patient’s blood or tissue samples to clinical laboratories, where trained scientists perform testing and data interpretation.... Read more

Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey

Data plays a key role in the transformation of today’s digital laboratories, acting both as a key challenge and a catalyst for innovation, as revealed by a survey of over 150 scientists.... Read more

Image: Structure of the herpes virus, nanopore module, and its waveform (Hashida et al., PNAS Nexus (2025), doi.org/10.1093/pnasnexus/pgaf161)

AI-Assisted Non-DNA Based Test Identifies Viral Infections in Minutes

Confirming viral infections typically involves DNA sequencing tests, which take hours and may not be available on-site. Moreover, these tests cannot differentiate between live and inactive virus particles.... Read more

Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more

Industry

view channel

Image: The AMP’s best practice recommendations are for clinical laboratories developing and performing HRD testing (Photo courtesy of 123RF)

AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing

Homologous recombination deficiency (HRD) testing identifies tumors that are unable to effectively repair DNA damage through the homologous recombination repair pathway. This deficiency is often linked... Read more

Image: Illumina’s acquisition of SomaLogic aims to strengthen its presence in the proteomics market (Photo courtesy of Illumina)

Illumina Acquires SomaLogic to Accelerate Proteomics Business

Illumina, Inc. (San Diego, CA, USA) has entered into a definitive agreement to acquire SomaLogic (Boulder, CO, USA), a leader in data-driven proteomics technology, and other specified assets for USD 350... Read more

Image: The new partnership aims to develop oncology assays for use on the QIAcuityDx platform (Photo courtesy of QIAGEN)

Qiagen and Gencurix Partner on Development of QIAcuity Digital PCR IVD Assay

QIAGEN (Venlo, Netherlands) and GENCURIX (Seoul, South Korea) have entered into a new partnership to develop oncology assays for use on the QIAcuityDx platform, a high-performance digital PCR system designed... Read more

QIAGEN and Incyte Enter into Precision Medicine Collaboration

Myeloproliferative neoplasms (MPNs) are a closely related group of rare blood cancers representing about 40% of hematological malignancies, characterized by chronic accumulation of different mature blood... Read more